The improvement in the proliferation, secretion, and cytotoxic activity of CD8+ TILs and a reduction in tumor-promoting cytokine production indicated that the sequential administration of anti-PD-1 and anti-Tim-3 antibodies with the Anchored GM-CSF vaccine induced a highly robust antitumor immune response. This evidence concerns the gene CD8A and neoplasm.